• Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biotec Pharmacon ASA

+ Add to Watchlist

BIOTEC:NO

17.900 NOK 0.600 3.47%

As of 10:25:09 ET on 10/01/2014.

Snapshot for Biotec Pharmacon ASA (BIOTEC)

Open: 17.300 Day's Range: 17.200 - 17.900 Volume: 110,565
Previous Close: 17.300 52wk Range: 5.600 - 24.500 1-Yr Rtn: +198.83%

Stock Chart for BIOTEC

No chart data available.
  • BIOTEC:NO 17.900
  • 1D
  • 1M
  • 1Y
17.300
Interactive BIOTEC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIOTEC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OBX -
Earnings Per Share (NOK) (ttm) -0.5800
Est. EPS (NOK) (12/2014) -0.4300
Est. PEG Ratio -
Market Cap (M NOK) 778.80
Shares Outstanding (M) 43.51
30 Day Average Volume 105,712
Price/Book (mrq) 7.2200
Price/Sale (ttm) 27.2902
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIOTEC

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for BIOTEC

Biotec Pharmacon ASA develops, manufactures and markets immune modulating compounds for the human and animal health sectors and marine enzymes used in molecular biology. The Company develops products to prevent or treat diseases caused by the failure, imbalance, and over-reaction of the immune system.

Svein W F LienChief Executive OfficerArvid VangenCFO/CAO
Rolf EngstadCSO
More Company Profile & Key Executives for BIOTEC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil